Biomarker analysis in a phase III study of pemetrexed–carboplatin versus etoposide–carboplatin in chemonaive patients with extensive-stage small-cell lung cancer-Reference-Cited by-同舟云学术

Biomarker analysis in a phase III study of pemetrexed–carboplatin versus etoposide–carboplatin in chemonaive patients with extensive-stage small-cell lung cancer

Published:2012-07 Issue:7 Volume:23 Page:1723-1729
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Smit E.F.,Socinski M.A.,Mullaney B.P.,Myrand S.P.,Scagliotti G.V.,Lorigan P.,Reck M.,Ciuleanu T.,von Pawel J.,Karaseva N.A.,Szczesna A.,Ohannesian D.,Powell E.,Hozak R.R.,Hong S.,Guba S.C.,Thatcher N.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/23/7/1723/16703417/mdr563.pdf

Reference35 articles.

1. Extensive-stage small-cell lung cancer: evolution of systemic therapy and future directions;Allen;Clin Lung Cancer,2008

2. American Cancer Society. Cancer Reference Information: All About Lung Cancer—Small Cell 2010; http://www.cancer.org/Cancer/LungCancer-SmallCell/DetailedGuide/index (24 October 2011, date last accessed)

3. Extensive stage small cell lung cancer;Gillenwater,2001

4. Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer;Socinski;J Clin Oncol,2009

5. Significance of thymidylate synthase gene expression level in patients with adenocarcinoma of the lung;Hashimoto;Cancer,2006

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non–Small Cell Lung Cancer: The Piedmont Study;Clinical Cancer Research;2023-05-26

2. Small Cell Lung Cancer;Encyclopedia of Respiratory Medicine;2022

3. Discovery of Novel Biomarkers of Therapeutic Responses in Han Chinese Pemetrexed-Based Treated Advanced NSCLC Patients;Frontiers in Pharmacology;2019-08-23

4. Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?;European Respiratory Journal;2017-06

5. Quantification and expert evaluation of evidence for chemopredictive biomarkers to personalize cancer treatment;Oncotarget;2016-11-24